CD274 and non-small cell lung carcinoma: Promoter methylation has been also reported be involved in regulation of PD-L1 expression epigenetically and treatment of DNA hypomethylating agent azacytidine can upregulate PD-L1 expression in NSCLC cells [12, 13].